Quanterix Corp
For the period ended Mar 31, 2025. Filed May 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 12, 2025
QTRX$3.38+16.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber | Exhibit Description | FiledHerewith | Incorporated byReference herein from Form or Schedule | Filing Date | SEC File/Reg.Number |
|---|---|---|---|---|---|
| 2.1* | Agreement and Plan of Merger, dated January 9, 2025, by and among the Registrant, Wellfleet Merger Sub, Inc., and Akoya Biosciences, Inc. | 8-K | 01/10/2025 | 001-38319 | |
| 2.2* | Amended and Restated Agreement and Plan of Merger, dated April 28, 2025, by and among the Registrant, Wellfleet Merger Sub, Inc., and Akoya Biosciences, Inc. | 8-K | 04/29/2025 | 001-38319 | |
| 3.1 | Amended and Restated Certificate of Incorporation. | 8-K | 12/15/2017 | 001-38319 | |
| 3.2 | Restated Bylaws. | 10-Q | 08/08/2023 | 001-38319 | |
| 10.1* | Voting and Support Agreement, dated January 9, 2025, by and among the Registrant and certain stockholders of Akoya Biosciences, Inc. named therein. | 8-K | 01/10/2025 | 001-38319 | |
| 10.1.1* | Consent and Waiver under, the Voting and Support Agreement, dated April 28, 2025, by and among the Registrant and certain stockholders of Akoya Biosciences, Inc. named therein. | 8-K | 04/29/2025 | 001-38319 | |
| 10.2* | Voting and Support Agreement, dated April 28, 2025, by and among the Registrant and certain stockholders of Akoya Biosciences, Inc. named therein. | 8-K | 04/29/2025 | 001-38319 | |
| 10.3 | Securities Purchase Agreement between the Registrant and Akoya Biosciences, Inc. dated April 2, 2025. | 8-K | 04/04/2025 | 001-38319 | |
| 10.3.1 | Form of Convertible Note | 8-K | 04/04/2025 | 001-38319 | |
| 10.3.2 | Form of Registration Rights Agreement | 8-K | 04/04/2025 | 001-38319 | |
| 10.3.3 | Form of Subordination Agreement | 8-K | 04/04/2025 | 001-38319 | |
| 10.4 | Amendment No. 1, dated April 28, 2025, to the Securities Purchase Agreement between the Registrant and Akoya Biosciences, Inc. dated April 2, 2025. | 8-K | 04/29/2025 | 001-38319 | |
| 31.1 | Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 31.2 | Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 32.1 | Certifications of the Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | |||
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | X | |||
| 101.SCH | XBRL Taxonomy Extension Schema Document. | X | |||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | X | |||
| 101.DEF | XBRL Taxonomy Extension Definition. | X |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document. | X |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. | X |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | X |
| * | Certain exhibits and schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Registrant hereby undertakes to furnish supplemental copies of any of the omitted exhibits and schedules upon request by the SEC; provided, however, that the Registrant may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any exhibits or schedules so furnished. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.